134 related articles for article (PubMed ID: 20645187)
1. Phosphoinositide-specific phospholipase C beta1 signal transduction in the nucleus.
Fiume R; Teti G; Faenza I; Cocco L
Methods Mol Biol; 2010; 645():143-64. PubMed ID: 20645187
[TBL] [Abstract][Full Text] [Related]
2. Nuclear phospholipase C beta1, regulation of the cell cycle and progression of acute myeloid leukemia.
Cocco L; Manzoli L; Palka G; Martelli AM
Adv Enzyme Regul; 2005; 45():126-35. PubMed ID: 16024064
[TBL] [Abstract][Full Text] [Related]
3. Physiology and pathology of nuclear phospholipase C β1.
Cocco L; Follo MY; Faenza I; Fiume R; Ramazzotti G; Weber G; Martelli AM; Manzoli FA
Adv Enzyme Regul; 2011; 51(1):2-12. PubMed ID: 21035488
[TBL] [Abstract][Full Text] [Related]
4. Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome.
Follo MY; Bosi C; Finelli C; Fiume R; Faenza I; Ramazzotti G; Gaboardi GC; Manzoli L; Cocco L
Int J Mol Med; 2006 Aug; 18(2):267-71. PubMed ID: 16820933
[TBL] [Abstract][Full Text] [Related]
5. Nuclear phospholipase C: involvement in signal transduction.
Manzoli L; Martelli AM; Billi AM; Faenza I; Fiume R; Cocco L
Prog Lipid Res; 2005 Jul; 44(4):185-206. PubMed ID: 15896848
[TBL] [Abstract][Full Text] [Related]
6. Phosphoinositide-phospholipase C beta1 mono-allelic deletion is associated with myelodysplastic syndromes evolution into acute myeloid leukemia.
Follo MY; Finelli C; Clissa C; Mongiorgi S; Bosi C; Martinelli G; Baccarani M; Manzoli L; Martelli AM; Cocco L
J Clin Oncol; 2009 Feb; 27(5):782-90. PubMed ID: 19114693
[TBL] [Abstract][Full Text] [Related]
7. Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients.
Follo MY; Mongiorgi S; Clissa C; Paolini S; Martinelli G; Martelli AM; Fioravanti G; Manzoli L; Finelli C; Cocco L
Leukemia; 2012 Dec; 26(12):2474-82. PubMed ID: 22596089
[TBL] [Abstract][Full Text] [Related]
8. Nuclear inositide signaling in myelodysplastic syndromes.
Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli AM; Cocco L
J Cell Biochem; 2010 Apr; 109(6):1065-71. PubMed ID: 20058233
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of nuclear PI-PLCbeta1 signaling pathway in low-risk MDS patients during azacitidine treatment.
Follo MY; Russo D; Finelli C; Mongiorgi S; Clissa C; Filì C; Colombi C; Gobbi M; Manzoli L; Piazzi M; Martelli AM; Cocco L
Leukemia; 2012 May; 26(5):943-50. PubMed ID: 22033492
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Inositide Signaling Via Phospholipase C.
Ratti S; Mongiorgi S; Ramazzotti G; Follo MY; Mariani GA; Suh PG; McCubrey JA; Cocco L; Manzoli L
J Cell Biochem; 2017 Aug; 118(8):1969-1978. PubMed ID: 28106288
[TBL] [Abstract][Full Text] [Related]
11. Nuclear PI-PLCβ1: an appraisal on targets and pathology.
Follo MY; Faenza I; Piazzi M; Blalock WL; Manzoli L; McCubrey JA; Cocco L
Adv Biol Regul; 2014 Jan; 54():2-11. PubMed ID: 24296032
[TBL] [Abstract][Full Text] [Related]
12. Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS.
Follo MY; Marmiroli S; Faenza I; Fiume R; Ramazzotti G; Martelli AM; Gobbi P; McCubrey JA; Finelli C; Manzoli FA; Cocco L
Adv Biol Regul; 2013 Jan; 53(1):2-7. PubMed ID: 23058275
[TBL] [Abstract][Full Text] [Related]
13. Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia.
Lo Vasco VR; Calabrese G; Manzoli L; Palka G; Spadano A; Morizio E; Guanciali-Franchi P; Fantasia D; Cocco L
Leukemia; 2004 Jun; 18(6):1122-6. PubMed ID: 15085153
[TBL] [Abstract][Full Text] [Related]
14. Expression of phospholipase C beta family isoenzymes in C2C12 myoblasts during terminal differentiation.
Faenza I; Bavelloni A; Fiume R; Santi P; Martelli AM; Maria Billi A; Lo Vasco VR; Manzoli L; Cocco L
J Cell Physiol; 2004 Aug; 200(2):291-6. PubMed ID: 15174099
[TBL] [Abstract][Full Text] [Related]
15. Nuclear PI-PLCβ1 and myelodysplastic syndromes: genetics and epigenetics.
Follo MY; Mongiorgi S; Finelli C; Piazzi M; Faenza I; Ramazzotti G; Santi P; McCubrey JA; Martelli AM; Cocco L
Curr Pharm Des; 2012; 18(13):1751-4. PubMed ID: 22352752
[TBL] [Abstract][Full Text] [Related]
16. Regulation of nuclear phospholipase C activity.
Manzoli L; Billi AM; Martelli AM; Cocco L
Acta Biochim Pol; 2004; 51(2):391-5. PubMed ID: 15218536
[TBL] [Abstract][Full Text] [Related]
17. Predominant expression of phospholipase Cbeta1 in telencephalic principal neurons and cerebellar interneurons, and its close association with related signaling molecules in somatodendritic neuronal elements.
Fukaya M; Uchigashima M; Nomura S; Hasegawa Y; Kikuchi H; Watanabe M
Eur J Neurosci; 2008 Nov; 28(9):1744-59. PubMed ID: 18973591
[TBL] [Abstract][Full Text] [Related]
18. Nuclear inositol lipid metabolism: more than just second messenger generation?
Martelli AM; Follo MY; Evangelisti C; Falà F; Fiume R; Billi AM; Cocco L
J Cell Biochem; 2005 Oct; 96(2):285-92. PubMed ID: 16088939
[TBL] [Abstract][Full Text] [Related]
19. Nuclear inositol lipid cycle: a new central intermediary in signal transduction.
Manzoli L; Gilmour RS; Martelli AM; Billi AM; Cocco L
Anticancer Res; 1996; 16(6A):3283-6. PubMed ID: 9042301
[TBL] [Abstract][Full Text] [Related]
20. New frontiers of inositide-specific phospholipase C in nuclear signalling.
Cocco L; Maraldi NM; Manzoli FA
Eur J Histochem; 2004; 48(1):83-8. PubMed ID: 15145779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
